A Rothe, H Schulz, T Elter, A Engert, M Reiser. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin’s lymphoma. haematol [Internet]. 2004Jul.1 [cited 2024Nov.23];89(7):875-6. Available from: https://haematologica.org/article/view/3158